查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566774

胃内球囊市场：按类型、填充材料、最终用户划分：2024-2033 年全球机会分析和产业预测

Intragastric Balloons Market By Type (Single, Dual, Triple), By Filling Material (Gas Filled, Saline Filled) By End User (Hospitals, Ambulatory Surgical Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 216 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球胃内球囊市场价值为3,220万美元，预计2024年至2033年复合年增长率为13.6%，到2033年将达到1.153亿美元。

胃内球囊是一种非手术医疗设备，旨在透过释放胃部空间、使人感到饱足并减少进食量来帮助人们减肥。透过内视镜手术将气球放入胃中，并充满生理食盐水或气体，占据胃的一部分并降低摄取食物的能力。这种方法可以帮助您坚持低热量饮食，养成更健康的饮食习惯，并支持减肥。这些球囊对于不适合或不希望避免胃绕道手术或袖状切除术等外科手术的肥胖患者特别有利。

推动胃内球囊市场成长的是与久坐的生活方式、不健康的饮食和遗传倾向等多种因素相关的肥胖盛行率的上升。随着这些因素在世界各地变得越来越普遍，肥胖的发生率持续上升。因此，越来越多的人正在寻求有效的减重解决方案，以降低这些健康风险并改善其整体健康。对肥胖管理解决方案不断增长的需求正在推动胃内球囊等干预措施的市场发展，这种干预措施提供了一种微创的减重方法。例如，57.0%寻求微创治疗的患者是在医疗专业人员的影响下做出决定的，因为他们被推荐进行微创治疗，并且报告治疗后较少感觉到缺点。

然而，报销政策的缺乏阻碍了胃内球囊的推广。在许多医疗保健系统中，胃内球囊治疗的保险范围预计不足或根本不存在，导致患者自付费用较高。这种经济障碍阻碍了患者寻求治疗，尤其是那些无法负担费用或保险范围不足的患者。另一方面，新产品的采用预示着市场成长的有利机会。例如，2022年9月，美国医疗设备製造商Allurion Technologies在印度推出了减重解决方案－可吞嚥式胃气球。该产品声称在16週内体重平均减轻10-15%。

分部概览

胃内球囊产业分为类型、填充材料、最终用户和地区。依类型可分为单层、双层和三层。根据填充材的不同，有充气型和生理食盐水型两种。依最终用户划分，可分为医院、门诊手术中心 (ASC) 等。从区域来看，分析涵盖北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按类型划分，2023 年胃内球囊市场中单一细分市场的收益最高。

从填充材料来看，2023年生理食盐水填充细分市场占据最高份额。

按最终用户划分，医院细分市场在 2023 年占据最大市场占有率。

按地区划分，北美在 2023 年占据胃内球囊市场的主导地位。

竞争场景

该报告可以定制。

  • 监管指引
  • 根据客户兴趣新增其他公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章胃内球囊市场：依类型

  • 市场概况
  • 单身的
  • 双重的
  • 三倍

第五章胃内球囊市场：依填充材料分类

  • 市场概况
  • 气体填充
  • 生理食盐水食盐水填充

第六章胃内球囊市场：依最终用户分类

  • 市场概况
  • 医院
  • 门诊手术中心
  • 其他的

第七章胃内球囊市场：依地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国胃内球囊市场
    • 加拿大胃内球囊市场
    • 墨西哥胃内球囊市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国胃内球囊市场
    • 德国胃内球囊市场
    • 义大利胃内球囊市场
    • 西班牙胃内球囊市场
    • 英国胃内球囊市场
    • 其他欧洲胃内球囊市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国胃内球囊市场
    • 日本胃内球囊市场
    • 印度胃内球囊市场
    • 韩国胃内球囊市场
    • 澳洲胃内球囊市场
    • 其他亚太地区胃内球囊市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西胃内球囊市场
    • 南非胃内球囊市场
    • 沙乌地阿拉伯胃内球囊市场
    • 其他拉丁美洲/中东/非洲胃内球囊市场

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第九章 公司简介

  • Obalon Therapeutics
  • Apollo Endosurgery Inc.
  • Allurion Technologies Inc.
  • Spatz Medical
  • ReShape Lifesciences
  • Lexel Medical
  • Endalis
  • MEDSIL
  • Silimed Industria De Implantes Ltda.
简介目录
Product Code: A03775

The global intragastric balloons market was valued at $32.2 million in 2023, and is projected to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.

Intragastric balloons are medical devices that do not require surgery and are created to aid in weight loss by taking up space in the stomach, leading to a sensation of fullness and decreased food consumption. These balloons are placed in the stomach through an endoscopic procedure and are filled with saline or gas to occupy a part of the stomach, reducing its capacity for food intake. This method helps people stick to low-calorie diets and develop healthier eating habits, which in turn supports weight loss. These balloons are especially advantageous for individuals dealing with obesity who may not be eligible for or prefer to avoid surgical procedures such as gastric bypass or sleeve gastrectomy.

The growth of the intragastric balloons market is driven by rise in the obesity rates related to various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. For instance, 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.

However, lack of reimbursement policies hinders the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures is expected to be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier deters individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. On the other hand, introduction of new products offers lucrative opportunities for the growth of the market. For instance, in September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks.

Segmentation Overview

The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is classified into single, dual, and triple. Depending on the filling material, it is bifurcated into gas filled and saline filled. According to end user, the market is categorized into hospitals, ambulatory surgical centers (ASC), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the single segment generated the largest revenue in the intragastric balloons market in 2023.

Depending on the filling material, the saline filled segment held the highest share in the market in 2023.

According to end users, the hospitals segment accounted for the largest market share in 2023.

Region wise, North America dominated the intragastric balloons market in 2023.

Competitive Scenario

The major players operating in the intragastric balloons market include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed. Other players in the intragastric balloons market include Districlass Medical, and Helioscopie. These players have adopted several strategies, including mergers & acquisitions, partnerships, collaborations, and product innovation & diversification to maintain their foothold in the market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type

  • Single
  • Dual
  • Triple

By Filling Material

  • Gas Filled
  • Saline Filled

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Obalon Therapeutics
    • Apollo Endosurgery Inc.
    • Allurion Technologies Inc.
    • Spatz Medical
    • ReShape Lifesciences
    • Lexel Medical
    • Endalis
    • MEDSIL
    • Silimed Industria de Implantes Ltda.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.5. Market Dynamics
    • 3.5.1. Drivers
    • 3.5.2. Restraints
    • 3.5.3. Opportunities

CHAPTER 4: INTRAGASTRIC BALLOONS MARKET, BY TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Type
  • 4.2. Single
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Dual
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Triple
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Filling Material
  • 5.2. Gas Filled
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Saline Filled
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: INTRAGASTRIC BALLOONS MARKET, BY END USER

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By End User
  • 6.2. Hospitals
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Others
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: INTRAGASTRIC BALLOONS MARKET, BY REGION

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By Region
  • 7.2. North America
    • 7.2.1. Key Market Trends and Opportunities
    • 7.2.2. Market Size and Forecast, By Type
    • 7.2.3. Market Size and Forecast, By Filling Material
    • 7.2.4. Market Size and Forecast, By End User
    • 7.2.5. Market Size and Forecast, By Country
    • 7.2.6. U.S. Intragastric Balloons Market
      • 7.2.6.1. Market Size and Forecast, By Type
      • 7.2.6.2. Market Size and Forecast, By Filling Material
      • 7.2.6.3. Market Size and Forecast, By End User
    • 7.2.7. Canada Intragastric Balloons Market
      • 7.2.7.1. Market Size and Forecast, By Type
      • 7.2.7.2. Market Size and Forecast, By Filling Material
      • 7.2.7.3. Market Size and Forecast, By End User
    • 7.2.8. Mexico Intragastric Balloons Market
      • 7.2.8.1. Market Size and Forecast, By Type
      • 7.2.8.2. Market Size and Forecast, By Filling Material
      • 7.2.8.3. Market Size and Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends and Opportunities
    • 7.3.2. Market Size and Forecast, By Type
    • 7.3.3. Market Size and Forecast, By Filling Material
    • 7.3.4. Market Size and Forecast, By End User
    • 7.3.5. Market Size and Forecast, By Country
    • 7.3.6. France Intragastric Balloons Market
      • 7.3.6.1. Market Size and Forecast, By Type
      • 7.3.6.2. Market Size and Forecast, By Filling Material
      • 7.3.6.3. Market Size and Forecast, By End User
    • 7.3.7. Germany Intragastric Balloons Market
      • 7.3.7.1. Market Size and Forecast, By Type
      • 7.3.7.2. Market Size and Forecast, By Filling Material
      • 7.3.7.3. Market Size and Forecast, By End User
    • 7.3.8. Italy Intragastric Balloons Market
      • 7.3.8.1. Market Size and Forecast, By Type
      • 7.3.8.2. Market Size and Forecast, By Filling Material
      • 7.3.8.3. Market Size and Forecast, By End User
    • 7.3.9. Spain Intragastric Balloons Market
      • 7.3.9.1. Market Size and Forecast, By Type
      • 7.3.9.2. Market Size and Forecast, By Filling Material
      • 7.3.9.3. Market Size and Forecast, By End User
    • 7.3.10. UK Intragastric Balloons Market
      • 7.3.10.1. Market Size and Forecast, By Type
      • 7.3.10.2. Market Size and Forecast, By Filling Material
      • 7.3.10.3. Market Size and Forecast, By End User
    • 7.3.11. Rest of Europe Intragastric Balloons Market
      • 7.3.11.1. Market Size and Forecast, By Type
      • 7.3.11.2. Market Size and Forecast, By Filling Material
      • 7.3.11.3. Market Size and Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends and Opportunities
    • 7.4.2. Market Size and Forecast, By Type
    • 7.4.3. Market Size and Forecast, By Filling Material
    • 7.4.4. Market Size and Forecast, By End User
    • 7.4.5. Market Size and Forecast, By Country
    • 7.4.6. China Intragastric Balloons Market
      • 7.4.6.1. Market Size and Forecast, By Type
      • 7.4.6.2. Market Size and Forecast, By Filling Material
      • 7.4.6.3. Market Size and Forecast, By End User
    • 7.4.7. Japan Intragastric Balloons Market
      • 7.4.7.1. Market Size and Forecast, By Type
      • 7.4.7.2. Market Size and Forecast, By Filling Material
      • 7.4.7.3. Market Size and Forecast, By End User
    • 7.4.8. India Intragastric Balloons Market
      • 7.4.8.1. Market Size and Forecast, By Type
      • 7.4.8.2. Market Size and Forecast, By Filling Material
      • 7.4.8.3. Market Size and Forecast, By End User
    • 7.4.9. South Korea Intragastric Balloons Market
      • 7.4.9.1. Market Size and Forecast, By Type
      • 7.4.9.2. Market Size and Forecast, By Filling Material
      • 7.4.9.3. Market Size and Forecast, By End User
    • 7.4.10. Australia Intragastric Balloons Market
      • 7.4.10.1. Market Size and Forecast, By Type
      • 7.4.10.2. Market Size and Forecast, By Filling Material
      • 7.4.10.3. Market Size and Forecast, By End User
    • 7.4.11. Rest of Asia-Pacific Intragastric Balloons Market
      • 7.4.11.1. Market Size and Forecast, By Type
      • 7.4.11.2. Market Size and Forecast, By Filling Material
      • 7.4.11.3. Market Size and Forecast, By End User
  • 7.5. LAMEA
    • 7.5.1. Key Market Trends and Opportunities
    • 7.5.2. Market Size and Forecast, By Type
    • 7.5.3. Market Size and Forecast, By Filling Material
    • 7.5.4. Market Size and Forecast, By End User
    • 7.5.5. Market Size and Forecast, By Country
    • 7.5.6. Brazil Intragastric Balloons Market
      • 7.5.6.1. Market Size and Forecast, By Type
      • 7.5.6.2. Market Size and Forecast, By Filling Material
      • 7.5.6.3. Market Size and Forecast, By End User
    • 7.5.7. South Africa Intragastric Balloons Market
      • 7.5.7.1. Market Size and Forecast, By Type
      • 7.5.7.2. Market Size and Forecast, By Filling Material
      • 7.5.7.3. Market Size and Forecast, By End User
    • 7.5.8. Saudi Arabia Intragastric Balloons Market
      • 7.5.8.1. Market Size and Forecast, By Type
      • 7.5.8.2. Market Size and Forecast, By Filling Material
      • 7.5.8.3. Market Size and Forecast, By End User
    • 7.5.9. Rest of LAMEA Intragastric Balloons Market
      • 7.5.9.1. Market Size and Forecast, By Type
      • 7.5.9.2. Market Size and Forecast, By Filling Material
      • 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top Winning Strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

  • 9.1. Obalon Therapeutics
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Company Snapshot
    • 9.1.4. Operating Business Segments
    • 9.1.5. Product Portfolio
    • 9.1.6. Business Performance
    • 9.1.7. Key Strategic Moves and Developments
  • 9.2. Apollo Endosurgery Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Key Executives
    • 9.2.3. Company Snapshot
    • 9.2.4. Operating Business Segments
    • 9.2.5. Product Portfolio
    • 9.2.6. Business Performance
    • 9.2.7. Key Strategic Moves and Developments
  • 9.3. Allurion Technologies Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Key Executives
    • 9.3.3. Company Snapshot
    • 9.3.4. Operating Business Segments
    • 9.3.5. Product Portfolio
    • 9.3.6. Business Performance
    • 9.3.7. Key Strategic Moves and Developments
  • 9.4. Spatz Medical
    • 9.4.1. Company Overview
    • 9.4.2. Key Executives
    • 9.4.3. Company Snapshot
    • 9.4.4. Operating Business Segments
    • 9.4.5. Product Portfolio
    • 9.4.6. Business Performance
    • 9.4.7. Key Strategic Moves and Developments
  • 9.5. ReShape Lifesciences
    • 9.5.1. Company Overview
    • 9.5.2. Key Executives
    • 9.5.3. Company Snapshot
    • 9.5.4. Operating Business Segments
    • 9.5.5. Product Portfolio
    • 9.5.6. Business Performance
    • 9.5.7. Key Strategic Moves and Developments
  • 9.6. Lexel Medical
    • 9.6.1. Company Overview
    • 9.6.2. Key Executives
    • 9.6.3. Company Snapshot
    • 9.6.4. Operating Business Segments
    • 9.6.5. Product Portfolio
    • 9.6.6. Business Performance
    • 9.6.7. Key Strategic Moves and Developments
  • 9.7. Endalis
    • 9.7.1. Company Overview
    • 9.7.2. Key Executives
    • 9.7.3. Company Snapshot
    • 9.7.4. Operating Business Segments
    • 9.7.5. Product Portfolio
    • 9.7.6. Business Performance
    • 9.7.7. Key Strategic Moves and Developments
  • 9.8. MEDSIL
    • 9.8.1. Company Overview
    • 9.8.2. Key Executives
    • 9.8.3. Company Snapshot
    • 9.8.4. Operating Business Segments
    • 9.8.5. Product Portfolio
    • 9.8.6. Business Performance
    • 9.8.7. Key Strategic Moves and Developments
  • 9.9. Silimed Industria De Implantes Ltda.
    • 9.9.1. Company Overview
    • 9.9.2. Key Executives
    • 9.9.3. Company Snapshot
    • 9.9.4. Operating Business Segments
    • 9.9.5. Product Portfolio
    • 9.9.6. Business Performance
    • 9.9.7. Key Strategic Moves and Developments